INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Proving The Return On Investment For eRegulatory

  Explore a study of how leading research centers, CROs, and sponsors cover the cost of eRegulatory tools … and then some.

• Patient-Reported Outcome In Oncology Clinical Trials

  As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.

• We Made Five Predictions For Clinical Research Last Year. Here's What Happened

  Review 2025’s gap between AI discovery and trial execution, highlighting legislative and FDA shifts to help sponsors operationalize participant experience for 2026.

• Interpreting Early Inflammation Signals: What Early Human Data Tells Us

  Early inflammatory signals can mislead without context. Benchmarked human challenge models reveal true biological activity, guiding decisions on mechanism, dosing, and clinical development.

• Improving Clinical Trial Performance Through Central eSource

  10/23/2025

  See how a top five pharmaceutical company leveraged our esource platform to enhance site performance, improve data consistency, and enable remote monitoring.

• IQVIA IRT - Putting The Focus On Driving Value For Our Customers

  2/27/2025

  IQVIA IRT senior leader and expert, Dan Pavitt, highlights key IRT initiatives aimed at enhancing customer value in this Clinical Leader Solutions Expo presentation.

• From Data To Decisions: Accelerating Clinical Development In The AI Era

  7/10/2026

  AI and connected data are reducing delays and complexity in clinical development — when paired with strong data foundations, smarter workflows, and human‑centered change.

• AI Needs A Home: Inside The Workflows That Drive Trials

  3/18/2026

  Move beyond fragmented digital tools. Learn how a governed execution layer transforms AI into a collaborator, streamlining trial decisions and creating a traceable record of human-AI insight.

• What Does 2025 Hold For Pharma?

  1/17/2025

  Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.